Dendritic cells (DCs) are antigen-presenting cells that play a critical role in initiating and regulating immune responses. In the context of cancer, DCs can present tumor antigens to T cells, thereby activating them to attack tumor cells. However, tumor-derived factors can impair DC function, leading to a weakened immune response against the tumor.
